Target intelligence / Profile preview

DENN domain-containing protein 1C (DENND1C)

Target
DENND1C
Molecular classification
Guanine nucleotide exchange factor (GEF), DENN domain-containing protein, Other
01

Overview

DENN domain-containing protein 1C (DENND1C, also known as connecdenn 3) is a guanine nucleotide exchange factor (GEF) that primarily functions to activate the small GTPase RAB35 by promoting the exchange of GDP for GTP, regulating endosomal membrane trafficking and actin polymerization[1][4][3]. Unlike related GEFs, DENND1C uses a unique C-terminal motif to directly bind actin, thereby coupling Rab35 activation to the actin cytoskeleton and resulting in changes to cell shape such as the formation of membrane protrusions[3]. While all three DENND1 family members (DENND1A–C) are GEFs for Rab35, DENND1C is characterized by a preference for actin-related processes, and has also shown low activity towards Rab8A and Rab13[3][4]. The gene is implicated in cellular proliferation, apoptosis, and receptor signaling, and associated diseases include congenital disorders of glycosylation type Iic[4]. Its knockout models are used in the exploration of gene function, particularly for understanding its role in health and disease, though no direct pharmacological agents targeting DENND1C or established biomarker or safety data are currently documented[1][4].

Other names
DENND1CFAM31CFLJ22757Connecdenn 3Protein FAM31CDENN/MADD domain containing 1Cfamily with sequence similarity 31 member Cconnecdenn 3
02

Mechanism of action

Activation of Rab GTPases via GDP-GTP exchange

03

Biological functions

Vesicle-mediated transportEndosomal membrane traffickingRegulation of actin polymerizationSignal transduction
04

Disease associations

Congenital disorder of glycosylation, type IicPotential roles in cancer and genetic disorders (experimental/associated, not fully established)

Beyond the preview

Go deeper on DENN domain-containing protein 1C (DENND1C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DENN domain-containing protein 1C (DENND1C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call